Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q2 2011 · 10-Q
Revenue$9.62B$9.62B+9.0% vs Q2 2010 Net Income$1.94B$1.94B+50.4% vs Q2 2010 EPS Diluted$1.23$1.23+48.2% vs Q2 2010 Gross Profit$5,745,800,000+8.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,503,152,000+6.6% Free Cash Flowderived$2,130,195,000+2.7% Margins · derivedGross margin59.8%−0.1 pt vs Q2 2010
Operating margin18.4%+0.2 pt vs Q2 2010
Net margin20.2%+5.6 pt vs Q2 2010
ended Jun 30, 2011 · filed Aug 4, 2011 · 35 d after period end